The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
If you look at this page this test looks very similar to the one that has been altered to identify Covid-19, or am I imagining that?
https://microgenbioproducts.com/pathflow/#1568996087520-8a95c379-6ba4
LOL
Just have a look at his posting history. Strange you don't mention HEMO anywhere? All the other stocks pumped on thin air but not HEMO. Odd that.
Negative when it suits you posting over and over again then positive. You have zero integrity sorry but you don't.
The difference between revenues from FY19 to Fy20 will be insane. Moreover NCYT have as a result of a global pandemic now firmly placed themselves in the global stage. Tell me another firm that currently has been able tor each every corner of the planet? What a piece of marketing for the long-term yes LONG-TERM benefit of this company. It is transformational.
DGR1980 you are at liberty to listen to whom you like. I won't be trying to remove money from your wallet.
The board will be full of people trying to engender doubt, making crazy suggestions. Just think that these people are email fraudsters or cold-callers. would you listen to them and believe them? Simple really.
So TF are selling a 96 test kit for €1530 or £1334 which equates to circa £13.89 per test so previous postings of £8 revenue per test seem very plausible.
I did think that too but then thought could it be 'Thame' as in Oxforshire and not Thane as written in section . if that's the case then its these guys in Thame and Cambridge.
https://cn-bio.com
That’s an excellent find indeed.
Ade it's 'lose' not 'loose' and I'm not worried and I doubt other than those that get duped by the level of no fact based negativity we're all ok thanks.
At this SP and on AIM we are attracting a different type of investor. Not someone thinking oh wait 'we're' doing the same type of thing as NCYT and our SP is less than a £1 or less than 30p or less than 4p etc.
There will be a lot of placings for cash poor businesses trying to develop some of the most expensive products you can within healthcare.
NCYT have NO cash issues they just keep generating millions and millions in revenue all across the planet. Happy days.
Thanks for the title 'Mad' to listen to anything you say. 'Mad' to be out of this. Lots of other posters that are either the same with multiple accounts or in groups. Just ignore it's boring. It's like Groundhog Day. Seriously try the other shares floating up on thin air.
So will try again why is it that stt1 you only post negatives? would you like to share with the board?
stt1 can I ask why is the only position of your postings wholly negative? It's totally imbalanced.
Lots of 50k and 100k buys going through mixed up with some 150k and 200k buys. Finally.
Yes it's under the Technical analysis tab and yes I am from Wales
I read thx for the sarcasm however.
Resistance, or a resistance level, is the price point at which the rise in the price of an asset is halted by the emergence of a growing number of sellers who wish to sell at that price. Resistance levels can be short-lived if new information comes to light that changes the overall market’s attitude toward the asset, or they can be long-lasting. In terms of technical analysis, the simple resistance level can be charted by drawing a line along the highest highs for the time period being considered.
It's taken from I n v e s t I n g . c o m I'm no genius but I use this for all live price action RSI - relative strength index in terms of signals which way prices are going etc. Useful for all LSE shares. Updated live
1 - 447.28, 2 - 483.32, 3 - 506.89
It blasted through the previous 3 in 10 minutes.
Shares that have no definite but promise it 'might' be good SP drops.
RNS with FACTS i.e. real revenue helps consolidate the SP as it creates REAL value not 'POTENTIAL'
and supports a company's valuation.
Looking forward to more REAL value RNS's :-) very very soon!